Relypsa to Present at Two Upcoming Conferences
02. September 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) today announced that the company will present at two upcoming investor conferences in September 2015.
Kristine...
Relypsa Announces New Employment Inducement Grants
18. August 2015 16:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 17, 2015, the compensation committee of the company's...
Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States
10. August 2015 16:06 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced it has entered a two-year detailing agreement with Sanofi for Patiromer...
Relypsa and Vifor Fresenius Medical Care Renal Pharma Enter Into Partnership to Commercialize Patiromer FOS in Europe and Additional Territories
10. August 2015 16:05 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., and ST. GALLEN, Switzerland, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, and Vifor Fresenius Medical Care Renal Pharma Ltd....
Relypsa Announces Second Quarter 2015 Financial Results
06. August 2015 16:15 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today reported financial results for the quarter ended June 30, 2015. Net loss for the...
Relypsa Announces New Employment Inducement Grants
05. August 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 3, 2015, the compensation committee of the company's...
Relypsa to Present at the 2015 Wedbush PacGrow Healthcare Conference
03. August 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the 2015 Wedbush PacGrow...
Relypsa Announces New Employment Inducement Grants
24. Juli 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., July 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 15, 2015, the compensation committee of the company's...
JAMA Publishes Long-Term Safety and Efficacy Results of Trial With Relypsa's Patiromer FOS Over One Year
14. Juli 2015 11:48 ET
|
Relypsa, Inc.
Patiromer FOS significantly decreased blood potassium levels in patients with chronic kidney disease and hyperkalemia at four weeks (primary endpoint)
Potassium levels were maintained at...
Relypsa Announces New Employment Inducement Grants
02. Juli 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., July 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 1, 2015, the compensation committee of the company's board...